...
首页> 外文期刊>The European journal of general practice. >Improving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care
【24h】

Improving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care

机译:改善初级保健中的药物安全性。 LINNEAUS合作组织对初级保健患者安全的审查和共识程序

获取原文
           

摘要

Background: Drug treatment is an important clinical process in primary care that is associated with risk of error and adverse events.Objective: To review currently available research evidence on the topic and to develop a framework, which can help to guide improvement of medication safety.Methods: Systematic reviews were performed on adverse drug events (ADE), their preventability, and on available tools and methods to improve medication safety with a particular focus on information technology. Consensus methods were used to develop a framework to guide the improvement of medication safety based on the findings of our literature review.Results: The median prevalence rate of ADEs in primary care patients was 12.8%. Only a median of 16.5% of ADEs were preventable and thus could be classified as medication errors. Our review of information technology interventions found that only about half of the studies found a reduction of medication errors. In both reviews, the wide range between studies emphasizes the necessity of a validated medication error classification system. Another important aspect of medication safety appears to be a general lack of safety culture in primary care, which led us to the development of the Salzburg medication safety framework (SaMSaF), based on the MaPSaF tool to improve patient safety. The tool proved to be feasible and useful in a pilot study with several GP practices.Conclusion: A number of tools and interventions to investigate and enhance medication safety have been identified. Further research is necessary to implement and evaluate current concepts.
机译:背景:药物治疗是基层医疗中重要的临床过程,与错误和不良事件的风险相关。目的:审查有关该主题的当前可用研究证据并建立框架,以帮助指导药物安全性的改善。方法:对药物不良事件(ADE),其可预防性以及提高药物安全性的可用工具和方法进行了系统评价,特别是信息技术方面。在我们的文献综述的基础上,使用共识方法来建立指导药物安全性改善的框架。结果:基层医疗患者的ADEs患病率中位数为12.8%。只有中位数的16.5%的ADE是可以预防的,因此可以归类为用药错误。我们对信息技术干预措施的审查发现,只有大约一半的研究发现减少了用药错误。在这两项评论中,研究之间的广泛范围强调了经过验证的药物错误分类系统的必要性。药物安全性的另一个重要方面似乎是初级保健机构普遍缺乏安全文化,这促使我们开发了基于MaPSaF工具的萨尔茨堡药物安全框架(SaMSaF),以提高患者的安全性。事实证明,该工具在具有多种GP实践的试点研究中是可行和有用的。结论:已确定了许多用于调查和增强药物安全性的工具和干预措施。实施和评估当前概念需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号